Paclitaxel downregulates tissue factor in cancer and host tumour-associated cells

European Journal of Cancer

Volumn 45, Issue 3, 2009, Pages 470-477

  Napoleone, Emanuela ^a   Zurlo, Filomena ^a   Latella, Maria Carmela ^a   Amore, Concetta ^b   Di Santo, Angelomaria ^b   Iacoviello, Licia ^a   Donati, Maria Benedetta ^a   Lorenzet, Roberto ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Cancer cells; Endothelial cells; Monocytes; Paclitaxel; Tissue factor

Indexed keywords

ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PACLITAXEL; PROCOAGULANT; THROMBOPLASTIN;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL DISRUPTION; CELL ISOLATION; CYTOKINE PRODUCTION; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HOST CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INCUBATION TIME; MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; UMBILICAL VEIN;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CELLS, CULTURED; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; PACLITAXEL; THROMBOPLASTIN;

EID: 59349117682     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.10.014     Document Type: Article

References (43)

1. Rowinsky E.K. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 48 (1997) 353-374
2. Jordan M.A., and Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 10 (1998) 123-130
3. Bogdan C., and Ding A. Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages. J Leukoc Biol 52 (1992) 119-121
4. White C.M., Martin B.K., Lee L.F., Haskill J.S., and Ting J.P. Effects of paclitaxel on cytokine synthesis by unprimed human monocytes, T lymphocytes, and breast cancer cells. Cancer Immunol Immunother 46 (1998) 104-112
5. Moos P.J., and Fitzpatrick F.A. Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis. Proc Natl Acad Sci USA 95 (1998) 3896-3901
6. Moos P.J., Muskardin D.T., and Fitzpatrick F.A. Effect of taxol and taxotere on gene expression in macrophages: induction of the prostaglandin H synthase-2 isoenzyme. J Immunol 162 (1999) 467-473
7. Zaks-Zilberman M., Zaks T.Z., and Vogel S.N. Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines. Cytokine 15 (2001) 156-165
8. Wang J., Lou P., Lesniewski R., and Henkin J. Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly. Anticancer Drugs 14 (2003) 13-19
9. Nemerson Y. Tissue factor and hemostasis. Blood 71 (1988) 1-8
10. Donati M.B., and Lorenzet R. The role of blood clotting in tumor metastasis: a case for tissue factor. In: Lugassy G., Falanga A., Kakkar A.K., and Rickles F.R. (Eds). Thrombosis and cancer (2004), Martin Dunitz Limited, London 47-58
11. Rickles F.R., Patierno S., and Fernandez P.M. Tissue factor, thrombin, and cancer. Chest 124 Suppl. 3 (2003) 58S-68S
12. Donati M.B., and Semeraro N. Cancer cell procoagulants and their pharmacological modulation. Haemostasis 14 (1984) 422-429
13. Versteeg H.H., Spek C.A., Peppelenbosch M.P., and Richel D.J. Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol Med 10 (2004) 6-11
14. Ruf W., and Mueller B.M. Thrombin generation and the pathogenesis of cancer. Semin Thromb Hemost 32 Suppl. 1 (2006) 61-68
15. Mueller B.M., and Ruf W. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest 101 (1998) 1372-1378
16. Bromberg M.E., Konigsberg W.H., Madison J.F., Pawashe A., and Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 92 (1995) 8205-8209
17. Belting M., Dorrell M.I., Sandgren S., et al. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 10 (2004) 502-509
18. Lorenzet R., Peri G., Locati D., et al. Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood 62 (1983) 271-273
19. Morgan D., Edwards R.L., and Rickles F.R. Monocyte procoagulant activity as a peripheral marker of clotting activation in cancer patients. Haemostasis 18 (1988) 55-65
20. Lwaleed B.A., Bass P.S., and Cooper A.J. The biology and tumour-related properties of monocyte tissue factor. J Pathol 193 (2001) 3-12
21. Contrino J., Hair G., Kreutzer D.L., and Rickles F.R. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nature Med 2 (1996) 209-215
22. Milsom C., Yu J., May L., et al. The role of tunor- and host-related tissue factor pools in oncogene-driven tumor progression. Thromb Res 120 Suppl. 2 (2007) S82-S91
23. Napoleone E., Di Santo A., and Lorenzet R. Monocytes upregulate endothelial cell expression of tissue factor: a role for cell-cell contact and cross-talk. Blood 89 (1997) 541-549
24. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-548
25. Falanga A., and Donati M.B. Pathogenesis of thrombosis in patients with malignancy. Int J Hematol 73 (2001) 137-144
26. Levine M.N., Lee A.Y., and Kakkar A.K. From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer. J Thromb Haemost 1 (2003) 1456-1463
27. Lorenzet R., Napoleone E., Celi A., Pellegrini G., and Di Santo A. Cell-cell interaction and tissue factor expression. Blood Coagul Fibrinol 9 Suppl. 1 (1998) S49-59
28. Fitzpatrick F.A., and Wheeler R. The immunopharmacology of paclitaxel (Taxol), docetaxel (Taxotere), and related agents. Int Immunopharmacol 3 (2003) 1699-1714
29. Crown J., and O'Leary M. The taxanes: an update. Lancet 355 (2000) 1176-1178
30. Belotti D., Vergani V., Drudis T., et al. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 2 (1996) 1843-1849
31. Ishihara M., Fujita M., Obara K., et al. Controlled releases of FGF-2 and paclitaxel from chitosan hydrogels and their subsequent effects on wound repair, angiogenesis, and tumor growth. Curr Drug Deliv 3 (2006) 351-358
32. Lau D.H., Xue L., Young L.J., Burke P.A., and Cheung A.T. Paclitaxel (Taxol): an inhibitor of angiogenesis in a highly vascularized transgenic breast cancer. Cancer Biother Radiopharm 14 (1999) 31-36
33. Toiyama Y., Inoue Y., Hiro J., et al. The range of optimal concentration and mechanisms of paclitaxel in radio-enhancement in gastrointestinal cancer cell lines. Cancer Chemother Pharmacol 59 (2007) 733-742
34. Loo W.T., Fong J.H., Cheung M.N., and Chow L.W. The efficacy of Paclitaxel on solid tumour analysed by ATP bioluminescence assay and VEGF expression: a translational research study. Biomed Pharmacother 59 Suppl. 2 (2005) S337-S339
35. Carmeliet P., Mackman N., Moons L., et al. Role of tissue factor in embryonic blood vessel development. Nature 383 (1996) 73-75
36. Wojtukiewicz M.Z., Sierko E., and Rak J. Contribution of the hemostatic system to angiogenesis in cancer. Semin Thromb Hemost 30 (2004) 5-20
37. Fernandez P.M., Patierno S.R., and Rickles F.R. Tissue factor and fibrin in tumor angiogenesis. Semin Thromb Hemost 30 (2004) 31-44
38. Manthey C.L., Brandes M.E., Perera P.Y., and Vogel S.N. Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J Immunol 149 (1992) 2459-2465
39. Kirikae T., Ojima I., Fuero-Oderda C., et al. Structural significance of the acyl group at the C-10 position and the A ring of the taxane core of paclitaxel for inducing nitric oxide and tumor necrosis factor production by murine macrophages. FEBS Lett 478 (2000) 221-226
40. Stähli B.E., Camici G.G., Steffel J., et al. Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation. Circ Res 99 (2006) 149-155
41. Aird W.C. Vascular bed-specific thrombosis. J Thromb Haemost 5 Suppl. 1 (2007) 283-291
42. Mackman N. Tissue-specific hemostasis in mice. Arteriscler Thromb Vasc Biol 25 (2005) 2273-2281
43. Eisenreich A., Celebi O., Goldin-Lang P., Schultheiss H.P., and Rauch U. Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel. Int Immunopharmacol 8 (2008) 307-311